Exploration of antimicrobial potential of Microbacterium barkeri secondary metabolites: A combined experimental and in silico approach

Abstract

Halophilic Actinobacterial colonies produce secondary metabolites as a defense mechanism, exhibiting antibacterial, antitumor, and anti-inflammatory properties. The current research explores the antimicrobial properties of secondary metabolites from Actinobacteria (Microbacterium barkeri) through a comprehensive approach that combines experimental and computational techniques. The Disc diffusion Method revealed significant antimicrobial activity. This underscores its potential as a powerful antimicrobial agent, warranting further investigation. In this study, comparative analysis indicates a link between the composition of secondary metabolites and their antimicrobial efficacy. In silico modelling, particularly molecular docking, was utilized to evaluate the interaction of selected bioactive compounds with antimicrobial receptors Staphylococcus aureus (4rco and 4rho), Staphylococcus epidermidis (1r17), Candida (1zap), and Trichophyton rubrum (7p1q). Compounds like Thiocarbamic acid, N-N-dimethyl, displayed interactions comparable to or superior to standard drugs (Cephalexin), suggesting their potential as promising drug candidates. However, the valuable insights the results provided underscore the importance of conducting thorough experimental validations, such as in vitro and in vivo studies, to confirm the efficacy and safety of identified compounds. It opens up avenues for future research by stressing the need to extensively explore specific bioactive compounds, Thiocarbamic acid, N-N-dimethyl, which could lead to the development of new antimicrobial therapeutics. This interdisciplinary study establishes a groundwork for understanding the therapeutic potential of actinobacterial secondary metabolites and provides a roadmap for creating antimicrobial drugs from natural sources.

Keywords

• Actinobacteria
• Bioactive compounds
• Antimicrobial
• In silico modelling
• Therapeutic potential

References

1. Abdullahi, M., Shallangwa, G.A., & Uzairu, A. (2020). In silico QSAR and molecular docking simulation of some novel aryl sulfonamide derivatives as inhibitors of H5N1 influenza A virus subtype. Beni Suef University Journal of Basic and Applied Sciences, 9(1), 2. https://doi.org/10.1186/s43088-019-0030-1
2. Attique, S.A., Hassan, M., Usman, M., Atif, R.M., Mahboob, S., Al-Ghanim, K.A., ... & Nawaz, M.Z. (2019). A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension. International Journal of Environmental Research and Public Health, 16(6), 923. https://doi.org/10.3390/ijerph16060923
3. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., & Bourne, P.E. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
4. Chung, J., Kim, S., Choi, K., & Kim, J.O. (2016). Degradation of polyvinyl alcohol in textile wastewater by Microbacterium barkeri KCCM 10507 and Paenibacillus amylolyticus KCCM 10508. Environmental Technology, 37(4), 452–458. https://doi.org/10.1080/09593330.2015.1060490
5. Das, K.K., & Pattnaik, S. (2024). Bioactivity of Microbacterium barkeri (LMA4) in vitro and candidate gene annotation in silico. Applied Biochemistry and Biotechnology, 196(5), 2839–2850. https://doi.org/10.1007/s12010-023-04519-5
6. Sheik, G.B., Maqbul, M.S., Shankar, G.S., & Ranjith, M.S. (2017). Isolation and characterization of actinomycetes from soil of Ad-Dawadmi, Saudi Arabia and screening their antibacterial activities. International Journal of Pharmacy and Pharmaceutical Sciences, 9(10), 276 279. https://doi.org/10.22159/ijpps.2017v9i10.15402
7. Isyaku, Y., Uzairu, A., & Uba, S. (2020). Computational studies of a series of 2-substituted phenyl-2-oxo-, 2-hydroxyl- and 2-acylloxyethylsulfonamides as potent anti-fungal agents. Heliyon, 6(4), e03744. https://doi.org/10.1016/j.heliyon.2020.e03744
8. Jiang, H.L., Xuan, Y., Zeng, Q., Yu, Q.M., Zhang, Y.Q., Chen, Y.R., Luo, H.B., Huang, H., & Xu, Q. (2021). Bioconversion of steviol glycosides into steviol by Microbacterium barkeri. Journal of Asian Natural Products Research, 23(11), 1057–1067. https://doi.org/10.1080/10286020.2020.1768868

9. Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B.A., Thiessen, P.A., Yu, B., Zaslavsky, L., Zhang, J., & Bolton, E.E. (2019). PubChem 2019 update: Improved access to chemical data. Nucleic Acids Research, 47(D1), D1102–D1109. https://doi.org/10.1093/nar/gky1033
10. Leng, W., Liu, T., Li, R., ... & He, C. (2008). Proteomic profile of dormant Trichophyton rubrum conidia. BMC Genomics, 9, 303. https://doi.org/10.1186/1471-2164-9-303
11. Levdansky, E., Kashi, O., Sharon, H., ... & Shadkchan, Y. (2010). The Aspergillus fumigatus cspA gene encoding a repeat-rich cell wall protein is important for normal conidial cell wall architecture and interaction with host cells. Eukaryotic Cell, 9(9), 1403–1415. https://doi.org/10.1128/EC.00055-10
12. Li, W., Yu, D., Gao, S., Lin, J., Chen, Z., & Zhao, W. (2014). Role of Candida albicans-secreted aspartyl proteinases (Saps) in severe early childhood caries. International Journal of Molecular Sciences, 15(6), 10766–10779. https://doi.org/10.3390/ijms150610766
13. Lian, C.H., & Liu, W.D. (2007). Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis. Mycoses, 50(5), 383 390. https://doi.org/10.1111/j.1439-0507.2007.01384.x
14. Liu, J., Zhou, Q., Ibrahim, M., Liu, H., Jin, G., Zhu, B., & Xie, G. (2011). Genome sequence of the biocontrol agent Microbacterium barkeri strain. Journal of Bacteriology, 194(23), 6666–6667. https://doi.org/10.1128/JB.00825-12
15. Marconi, V.C., Kradin, R., Marty, F.M., ... Baden, L.R. (2010). Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: Case report and review of the literature. Medical Mycology, 48(4), 518–527. https://doi.org/10.3109/13693780903295968
16. Mohana, R., & Venugopal, S. (2017). In silico analysis of toxins of Staphylococcus aureus for validating putative drug targets. Infectious Disorders – Drug Targets, 17(2), 130 142. https://doi.org/10.2174/1871526516666161230150219
17. Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., & Olson, A.J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
18. Mustapha, A., Shallangwa, G., Ibrahim, M.T., Bello, A.U., Ebuka, D.A., Uzairu, A., & Mamza, P. (2018). QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer agents against leukemia cell line (K562). Journal of the Turkish Chemical Society Section A: Chemistry, 5(3), 1387–1398. https://doi.org/10.18596/jotcsa.454040
19. Naglik, J.R., Newport, G., White, T.C., ... Hube, B. (1999). In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infection and Immunity, 67(5), 2482–2490. https://doi.org/10.1128/IAI.67.5.2482-2490.1999
20. Parashar, S., & Kumar, N. (2021). Isolation and characterization of a novel agar-degrading bacterium, Microbacterium barkeri sp. Sela 4, from soil enriched with laboratory agar. Journal of Microbiology, Biotechnology and Food Sciences, 10(1), 78–83. https://doi.org/10.15414/jmbfs.2021.10.1.78-83
21. Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., & Ferrin, T.E. (2004). UCSF Chimera-A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
22. Philip, B.M., John, J.S., Kumar, K.M., Devarajegowda, H.C., Chandy, J., & Sajan, D. (2018). Molecular docking and spectral analysis of (5,7-dimethyl-2-oxo-2H-chromen-4-yl)-methyl diethyldithiocarbamate: A potential bioactive agent. Chemical Physics Letters, 711, 87–99. https://doi.org/10.1016/j.cplett.2018.09.008
23. Ponnuraj, K., Bowden, M.G., Davis, S., Gurusiddappa, S., Moore, D., Choe, D., ... & Narayana, S.V. (2003). A “dock, lock, and latch” structural model for a staphylococcal adhesin binding to fibrinogen. Cell, 115(2), 217–228. https://doi.org/10.1016/S0092-8674(03)00809-2
24. Mazzola, P.G., Jozala, A.F., Novaes, L.C.L., Moriel, P., & Penna, T.C.V. (2009). Minimal inhibitory concentration (MIC) determination of disinfectant and/or sterilizing agents. Brazilian Journal of Pharmaceutical Sciences, 45(2), 241–248. https://doi.org/10.1590/S1984-82502009000200007
25. Schaller, M., Schäfer, W., Korting, H.C., & Hube, B. (1998). Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Molecular Microbiology, 29(3), 605–615. https://doi.org/10.1046/j.1365-2958.1998.00957.x
26. Sharma, S., Mathur, N., Singh, A., & Agarwal, M. (2022). Biodegradation of low- and high-density polyethylene films by Microbacterium barkeri SH20. Current World Environment, 17(1), 245–253. https://doi.org/10.12944/CWE.17.1.27
27. Srikrishna, D., Godugu, C., & Dubey, P.K. (2018). A review on pharmacological properties of coumarins. Mini Reviews in Medicinal Chemistry, 18(2), 113 141. https://doi.org/10.2174/1389557516666160801094919
28. Stanchev, S., Hadjimitova, V., Traykov, T., Boyanov, T., & Manolov, I. (2009). Investigation of the antioxidant properties of some new 4-hydroxycoumarin derivatives. European Journal of Medicinal Chemistry, 44(7), 3077–3082. https://doi.org/10.1016/j.ejmech.2008.07.007
29. Stefanachi, A., Leonetti, F., Pisani, L., Catto, M., & Carotti, A. (2018). Coumarin: A natural, privileged and versatile scaffold for bioactive compounds. Molecules, 23(2), 250. https://doi.org/10.3390/molecules23020250
30. Tanuja, P.J. (2017). Molecular characterization of cellulase producing Microbacterium barkeri isolated from agricultural waste. International Journal of Advanced Research, 5(8), 1344 1349. https://doi.org/10.21474/IJAR01/5292